EMA — authorised 12 October 2004
- Application: EMEA/H/C/000535
- Marketing authorisation holder: Recordati Rare Diseases
- Local brand name: Wilzin
- Indication: Treatment of Wilson's disease.
- Status: approved
🇪🇺 Prebiotic in European Union
EMA authorised Prebiotic on 12 October 2004
Marketing authorisation
Prebiotic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in European Union
Frequently asked questions
Is Prebiotic approved in European Union?
Yes. EMA authorised it on 12 October 2004.
Who is the marketing authorisation holder for Prebiotic in European Union?
Recordati Rare Diseases holds the EU marketing authorisation.